RACHAEL SHAPIRO: Open Payments
NPI 1700422102 · MINEOLA, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$870 in 33 payments from 11 companies in 2025. Trend: 2023 $602 · 2024 $212 · 2025 $870
Food & beverage: $870
| Company | Payments | Amount |
|---|---|---|
| Abbott Laboratories | 8 | $241 |
| Alnylam Pharmaceuticals Inc. | 8 | $180 |
| AstraZeneca Pharmaceuticals LP | 4 | $176 |
| PFIZER INC. | 3 | $68 |
| BridgeBio Pharma, Inc. | 3 | $58 |
| E.R. Squibb & Sons, L.L.C. | 2 | $42 |
| CVRx, Inc. | 1 | $25 |
| Actelion Pharmaceuticals US, Inc. | 1 | $22 |
| Novo Nordisk Inc | 1 | $21 |
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | 1 | $20 |
Products named: CARDIOMEMS, AMVUTTRA, WAINUA, VYNDAQEL, Attruby, Barostim Neo System, CAMZYOS, UPTRAVI.
Industry payments across NY — which companies pay providers there.
